Position in PAHC
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$797,497
+$138,755 QoQ
Shares Held
25,398
+113.2% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#73
of 207 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $8,299,759 across 12 Drug Manufacturers - Specialty & Generic names. PAHC ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
39,698 | $4,404,096 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
65,730 | $1,617,615 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
24,799 | $897,723 | |
| 4 | PAHC |
Phibro Animal Health Corp
This page
|
25,398 | $797,497 | |
| 5 | ZTS |
Zoetis Inc.
|
5,315 | $381,935 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
213 | $115,409 | |
| 7 | ALKS |
Alkermes plc.
|
700 | $36,680 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,242 | $21,499 |
All Filings in PAHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $797,497 | 25,398 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $658,742 | 11,910 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $456,912 | 12,230 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $428,430 | 10,589 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $252,462 | 9,885 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $230,965 | 10,813 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,704 | 224 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $3,760 | 167 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||